What it is
Inflammation in skin is driven by cytokines such as IL-1, IL-8, IL-17, and TNF-α, plus toll-like receptor signaling.
Both Cutibacterium acnes and Malassezia metabolites can activate these pathways and contribute to visible inflammatory features.
Reducing inflammatory signaling — without removing host immunity — is a shared treatment theme across many conditions.
Why it matters
Inflammation links microbes, sebum metabolites, and barrier disruption to the visible features users actually see and feel.
